The influence of HRT on bone mineral dencity, condition of parodontal complex tissue, clinical implications of articulated syndrome in postmenopausal women

Introduction. To evaluate the effect of hormone replacement therapy on periodontal treatment outcomes complex, bone mineral density and articular syndrome in a group of postmenopausal women.

Materials and methods. We carried out an exploration of 32 postmenopausal women aged 50-59 years , with chronic periodontitis, postmenopausal osteoporosis, hand osteoarthritis. The control group (n=14) didn’t receive HRT (HRT–). The test group (n=18) –received HRT (HRT+).All subjects were examined by recording the following: plaque index (PI), sulcus bleeding index (SBI), periodontal pocket depth (PD), Dreiser`s index, VAS pain score. Measurements were recorded at the baseline, 1 month, 3 months, and 6 monthsю Results. The significant decline was revealed in all of the values (PI, SBI, PD) in HRT+ compare to HRT-. After 6, 12 months, in the periodontal area had been stabilized in the HRT+ group. 11.2% reduction was indicated in the lumbar spine and 8,15% reduction in the femoral neck within the HRTafter 1 year. The significant decrease was discovered in VAS pain score, Dreiser`s index, painful joints quantity in HRT+.

Conclusions: 12-week HRT was highly effective in periodontal treatment outcomes (significant decrease in PI, SBI, PD after 3 months). BMD of the femoral neck and lumbar spine is reduced within 1 year in patients with MHTcompared with MHT +.In the group of MHT +, compared with the group of MHTand baseline data, after 3 months there was a significant improvement in the number of painful joints, the level of pain, the Dreiser index, a positive effect persists until the end of the study.

1. Gold E.B. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am. 2011;38(3):425–440. doi: 10.1016/j.ogc.2011.05.002.

2. Ceylan B., Ozerdoğan N. Factors affecting age of onset of menopause and determination of quality of life in menopause. Turk J Obstet Gynecol. 2015;12(1):43–49. doi: 10.4274/tjod.79836.

3. Cekici A., Baser U., Isik G., Akhan S.E., Issever H., Onan U. Periodontal treatment outcomes in post menopausal women receiving hormone replacement therapy. J Istanb Univ Fac Dent. 2015;49(3):39–44. doi: 10.17096/jiufd.61637.

4. Pizzo G., Guiglia R., Licata M.E., Pizzo I., Davis J.M., Giuliana G. Effect of hormone replacement therapy (HRT) on periodontal status of postmenopausal women. Med Sci Monit. 2011;17(4):PH23–PH27. doi: 10.12659/MSM.881700.

5. Ran S.Y., Yu Q., Chen Y., Lin S.Q. Prevention of postmenopausal osteoporosis in Chinese women: A 5-year, double-blind, randomized, parallel placebo-controlled study. Climacteric. 2017;20:391–396. doi: 10.1080/13697137.2017.1325459.

6. Lesnyak O.M., Baranova I.A., Belova K.Y., Gladkova E.N., Evstigneeva L.P., Ershova O.B. et al. Osteoporosis in russian federation: epidemiology, socio-medical and economical aspects (review). Travmatologiya i ortopediya Rossii = Traumatology and Orthopedics of Russia. 2018;24(1):155–168. (In Russ.) doi: 10.21823/2311-29052018-24-1-155-168.

7. Namkhanov V.V. Impact of the loss of mineral density of bone tissue on the periodontal status of patients. Vestnik Buryatskogo Gosudarstvennogo Universiteta. Meditsina i farmatsiya = Bulletin of Banzarov Buryat State University. Medicine and Pharmacy. 2014;(12):93–96. (In Russ.) Available at: https://elibrary.ru/item.asp?id=22532195.

8. Xue W., Deng Y., Wang Y.F., Sun A.J. Effect of half-dose and standard-dose conjugated equine estrogens combined with natural progesterone or dydrogesterone on components of metabolic syndrome in healthy postmenopausal women: A randomized controlled trial. Chin Med J (Eng). 2016;129:2773–2779. doi: 10.4103/0366-6999.194646.

9. Posch M., Schranz A., Lener M. et al. Effectiveness of a Mini-Trampoline Training Program on Balance and Functional Mobility, Gait Performance, Strength, Fear of Falling and Bone Mineral Density in Older Women with Osteopenia. Clin Interv Aging. 2019;14:2281–2293. doi: 10.2147/CIA.S230008.

10. Almeida M., Laurent M.R., Dubois V. et al. Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev. 2017;97(1):135–187. doi: 10.1152/physrev.00033.2015.

11. Kim M.J., Cho J., Ahn Y., Yim G., Park H.Y. Association between physical activity and menopausal symptoms in perimenopausal women. BMC Womens Health. 2014;14:122. doi: 10.1186/1472-6874-14-122.

12. Cosman F., de Beur S.J., LeBoff M.S., Lewiecki E.M., Tanner B., Randall S. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–2381. doi: 10.1007/s00198-014-2794-2.

13. Svedboum A., Hernlund E., Ivergard M., Compston J., Cooper C., Stenmark J. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013;8:137. doi: 10.1007/s11657-013-0137-0.

14. Rodriguez-Landa J.F., Puga-Olguin A., German-Ponciano L.J., Garcia-Rios R.I., SoriaFregozo C. Anxiety in Natural and Surgical Menopause Physiologic and Therapeutic Bases. In: Durbano F. A Fresh Look at Anxiety Disorders. London: IntechOpen; 2015, pp. 173–196. doi: 10.5772/60621

15. Kannus P., Sievanen H., Palvanen M., Jarvinen T., Parkkari J. Prevention of falls and consequent injuries in elderly people. Lancet. 2005;366(9500):1885–1893. doi: 10.1016/S0140-6736(05)67604-0.